Other studies demonstrated that circulating ApoM levels are significantly lower in individuals with obesity, metabolic syndrome, type 2 diabetes and gestational diabetes compared to lean, non-diabetic controls. This evidence concerns the gene APOM and type 2 diabetes mellitus.